Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 60-Minute group session and peer calls curb suicide crises?

NCT ID NCT07784634

Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Sep 04, 2026 · Updated 3 times

Summary

This trial tests whether adding a brief, recovery-focused therapy called THRIVE to standard crisis center care reduces suicide risk events—like repeat crisis visits, suicide attempts, or deaths—in the year after discharge. Adults admitted to crisis stabilization centers for suicidal thoughts will either receive usual care or usual care plus THRIVE, which includes one group session and up to six peer coaching calls. The study will also look at what helps or hinders bringing THRIVE into real-world crisis settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
THRIVE, a brief group psychotherapy session followed by up to six peer-led recovery coaching phone calls
What this could lead to
If effective, THRIVE could become a standard, low-cost addition to crisis stabilization care, reducing repeat crises and suicide attempts after discharge.
What could go wrong
This is an early-stage trial, and results may not show a clear benefit. The intervention is brief, and outcomes depend on follow-up engagement, which can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 552 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Oct 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Admission to CSC with suicidal crisis, as defined by active suicide ideation ascertained by the Columbia Suicide-Severity Rating scale (C-SSRS), which the sites already routinely administer 2. Ability and willingness to provide information and permission to contact at least one person in case of emergency or inability to reach the participant for follow-up. Exclusion Criteria: 1. Under age 18. 2. Inability to communicate with the researcher in English. 3. Acute psychiatric instability (e.g., psychotic symptoms) prohibiting participation in psychotherapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Behavioral: care as usual are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicide Suicide Prevention Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Behavioral: care as usual Behavioral: care as usual + thrive Suicide

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Connections Health Solutions

    Phoenix, Arizona, 85007, United States

  • Mental Health Cooperative

    Nashville, Tennessee, 35756, United States

  • Wellstone

    Huntsville, Alabama, 35802, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.